Dawn Tranchino Provenzale, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 411 W. Chapel Hill St, 7th Floor, Durham, NC 27701
Phone (919) 286-9408
Email address prove002@mc.duke.edu

Dr. Provenzale is Director of GI Outcomes Research at Duke University and the Director of the Durham Epidemiologic Research and Information Center (ERIC). She directs a research program that integrates observational research, measurement of patient-centered outcomes and decision making to investigate patient-oriented research questions in gastrointestinal cancer screening, surveillance and quality of care. Dr. Provenzale also directs the training program for GI fellows committed to careers in health services research.


Ongoing projects include CanCORS, an NCI/VA funded consortium to measure quality of lung and colorectal cancer care in VA and non-VA settings, and the development and dissemination of CCQMS, a cancer care quality measurement system. Additional studies are developing a cancer tissue repository for microarray studies.

Education and Training

  • Fellow in Clinical Decision Making, Medicine, Tufts University, 1989 - 1991
  • Fellow in Gastroenterology, Medicine, Tufts University, 1987 - 1990
  • Medical Resident, Medicine, University of North Carolina at Chapel Hill, 1984 - 1987
  • M.D., Albany Medical College, 1984


Yousuf, S. Y., A. P. Abernethy, D. H. Abbott, S. C. Grambow, J. E. Marcello, J. E. Herndon, K. L. Rowe, et al. “Comorbidity, age, race and stage at diagnosis in colorectal cancer: A retrospective, parallel analysis of two health systems.” Bmc Cancer 8 (November 25, 2008). https://doi.org/10.1186/1471-2407-8-345.

Full Text

Kahn, K. L., J. L. Adams, E. E. Chrischilles, D. P. Harrington, J. C. Weeks, J. Z. Ayanian, C. I. Kiefe, D. T. Provenzale, and R. H. Fletcher. “Are we use of chemotherapy for elderly stage III colon cancer patients? An analysis from the Cancer Care Outcomes & Research Surveillance Consortium (CanCORS).” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 6500–6500. https://doi.org/10.1200/jco.2008.26.15_suppl.6500.

Full Text

Brady, Carla W., Alastair D. Smith, Karen M. Stechuchak, Cynthia J. Coffman, Janet E. Tuttle-Newhall, Dawn Provenzale, and Andrew J. Muir. “Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era..” Liver Transpl 14, no. 2 (February 2008): 228–34. https://doi.org/10.1002/lt.21346.

Full Text

Lieberman, David A., David G. Weiss, William V. Harford, Dennis J. Ahnen, Dawn Provenzale, Stephen J. Sontag, Thomas G. Schnell, et al. “Five-year colon surveillance after screening colonoscopy..” Gastroenterology 133, no. 4 (October 2007): 1077–85. https://doi.org/10.1053/j.gastro.2007.07.006.

Full Text

Imperiale, Thomas F., Jason A. Dominitz, Dawn T. Provenzale, Lynn P. Boes, Cynthia M. Rose, Jill C. Bowers, Beverly S. Musick, Faouzi Azzouz, and Susan M. Perkins. “Predicting poor outcome from acute upper gastrointestinal hemorrhage..” Arch Intern Med 167, no. 12 (June 25, 2007): 1291–96. https://doi.org/10.1001/archinte.167.12.1291.

Full Text

Sultan, Shahnaz, Jason Conway, David Edelman, Tara Dudley, and Dawn Provenzale. “Colorectal cancer screening in young patients with poor health and severe comorbidity..” Arch Intern Med 166, no. 20 (November 13, 2006): 2209–14. https://doi.org/10.1001/archinte.166.20.2209.

Full Text

Arseneau, Kristen O., Shahnaz Sultan, Dawn T. Provenzale, Jane Onken, Stephen J. Bickston, Eugene Foley, Alfred F. Connors, and Fabio Cominelli. “Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?.” Clin Gastroenterol Hepatol 4, no. 9 (September 2006): 1135–42. https://doi.org/10.1016/j.cgh.2006.05.003.

Full Text